Cite
HARVARD Citation
Smith, M. et al. (2017). Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure. EMBO molecular medicine. 9 (8), pp. 1011-1029. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Smith, M. et al. (2017). Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure. EMBO molecular medicine. 9 (8), pp. 1011-1029. [Online].